Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Korc

Showing results (61-70 of 156) with videos related to

Pageof 16
Sort By:
Molecular Cancer Therapeutics|May 30, 2006
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancerTakuma Aikawa, Jason Gunn, Suzanne M Spong, et al.
Plos One|December 6, 2011
Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineageCatherine Carrière, Alison L Young, Jason R Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancerKnut Ketterer, Shyam Rao, Helmut Friess, et al.
Biochemical and Biophysical Research Communications|March 19, 2009
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasCatherine Carrière, Alison L Young, Jason R Gunn, et al.
International Journal of Oncology|June 18, 2004
Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formationJunsheng Li, Jörg Kleeff, Nathalia Giese, et al.
Best Practice & Research. Clinical Gastroenterology|December 3, 2017
Tobacco and alcohol as risk factors for pancreatic cancerMurray Korc, Christie Y Jeon, Mouad Edderkaoui, et al.
Cancer Letters|February 25, 2017
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancerXianyin Lai, Mu Wang, Samantha Deitz McElyea, et al.
Cancer Letters|February 7, 2021
Trials and tribulations of pancreatic cancer immunotherapyDaniel R Principe, Murray Korc, Suneel D Kamath, et al.
Nature Reviews. Disease Primers|January 19, 2018
Cancer-associated cachexiaVickie E Baracos, Lisa Martin, Murray Korc, et al.
Nano Letters|November 8, 2014
Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patientsGayatri K Joshi, Samantha Deitz-McElyea, Merrell Johnson, et al.
Pageof 16

Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
Molecular Cancer Therapeutics|May 30, 2006
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancerTakuma Aikawa, Jason Gunn, Suzanne M Spong, et al.
Plos One|December 6, 2011
Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineageCatherine Carrière, Alison L Young, Jason R Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancerKnut Ketterer, Shyam Rao, Helmut Friess, et al.
Biochemical and Biophysical Research Communications|March 19, 2009
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic KrasCatherine Carrière, Alison L Young, Jason R Gunn, et al.
International Journal of Oncology|June 18, 2004
Gefitinib ('Iressa', ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits pancreatic cancer cell growth, invasion, and colony formationJunsheng Li, Jörg Kleeff, Nathalia Giese, et al.
Best Practice & Research. Clinical Gastroenterology|December 3, 2017
Tobacco and alcohol as risk factors for pancreatic cancerMurray Korc, Christie Y Jeon, Mouad Edderkaoui, et al.
Cancer Letters|February 25, 2017
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancerXianyin Lai, Mu Wang, Samantha Deitz McElyea, et al.
Cancer Letters|February 7, 2021
Trials and tribulations of pancreatic cancer immunotherapyDaniel R Principe, Murray Korc, Suneel D Kamath, et al.
Nature Reviews. Disease Primers|January 19, 2018
Cancer-associated cachexiaVickie E Baracos, Lisa Martin, Murray Korc, et al.
Nano Letters|November 8, 2014
Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patientsGayatri K Joshi, Samantha Deitz-McElyea, Merrell Johnson, et al.
Pageof 16